Gene mutations necessary for mitochondrial fusion, such as OPA1 or Mfn2, can affect multiple tissues, leading to diseases such as autosomal dominant optic atrophy (DOA) and Charot-Marie-Tooth type 2A (CMT2A) respectively [53–55]. The gene discussed is MFN2; the disease is autosomal dominant optic atrophy.